AFYX Therapeutics Presents New Study Showing Therapeutic Antibody Delivery to Oral Mucosa Using Rivelin Biodegradable Mucoadhesive ...
Preclinical study demonstrates potential to deliver anti-TNFα antibody fragments topically to inflamed mucosal tissue using Rivelin technology SAN DIEGO & COPENHAGEN, Denmark--(BUSINESS WIRE)--AFYX Therapeutics (“AFYX”), a clinical-stage …